National and Kapodistrian University of Athens
Ανάπτυξη κυτταρογενετικών μεθοδολογιών για την εκτίμηση της ατομικής ακτινοευαισθησίας και αξιολόγηση σύγχρονων εξατομικευμένων τεχνικών ακτινοθεραπείας
Abstract
dc:descriptionWhile technological advances in radiation oncology have led to a more precise delivery of radiation dose and to a decreased risk of side effects, there is still a need to better understand at the DNA and cytogenetic level the mechanisms underlying DNA damage response (DDR) and to overcome tumor resistance. ATM, ATR and Chk1 kinases are key mediators in DDR activation and crucial factors in treatment resistance. It is of importance, therefore, as an alternative to the conventional clonogenic assay, to establish a cytogenetic assay enabling reliable and time-efficient results in evaluating the potency of DDR inhibitors for radiosensitization. Towards this goal, the present study aims: 1. To develop and optimize a G2-chromosomal radiosensitivity assay using DDR and G2-checkpoint inhibitors as a novel modification compared to the classical G2-assay. 2. To investigate the strengths of this assay, as an alternative to the conventional clonogenic assay, for rapid radiosensitivity assessments of cultured cell lines, and potentially of primary tumor cells obtained from biopsies. 3. To examine the strengths and feasibility of the assay in enabling time-efficient results regarding the evaluation of the potency of DDR inhibitors in radiosensitizing cells. Specifically, exponentially growing RPE and 82-6 hTERT human cells were irradiated during G2/M-phase transition in the presence or absence of Caffeine, VE-821 and UCN-1 inhibitors of ATM/ATR, ATR and Chk1 respectively, and the induced chromatid breaks were used to evaluate cell radiosensitivity and their potency for radiosensitization. The results generated here led to the development and optimization of a modified G2-assay using the VE-821 ATR inhibitor enabling time-efficient radiosensitivity assessments of cultured cells, and potentially of primary tumor cells obtained from biopsies. The results also, highlight the potential of our modified G2-assay using VE-821 to evaluate cell radiosensitivity, the efficacy of DDR inhibitors in radiosensitization, and reinforce the concept that ATM, ATR and Chk1 represent attractive anticancer drug targets in radiation oncology.Τhere is also a need to evaluate the efficacy of the new radiotherapy techniques estimating the biological dose and to investigate the radiobiological impact of the dose rate in advanced radiotherapy techniques. The aim of this experimental part is to compare, at a cytogenetic level, advanced radiotherapy techniques VMAT and IMRT with the conventional 3D-CRT, using biological dosimetry. A dicentric biodosimetry assay, based on the frequency of dicentrics chromosomes scored in peripheral blood lymphocytes from prostate cancer patients and PC3 human prostate cancer cell line was used. For each patient blood sample and for the cell line, three different irradiations were performed using the 3D-CRT, IMRT and VMAT technique. The absorbed dose was estimated with the biodosimetry method based on the induced dicentric chromosomes. The results showed a statistically significant underestimation of the biological absorbed dose of ~4% for the IMRT and VMAT compared to 3D-CRT irradiations for peripheral blood lymphocytes, whereas IMRT and VMAT results were comparable without a statistically significant difference, although slightly lower values were observed for VMAT compared to IMRT irradiation. Similar results were obtained using the PC3 cell line. The observed biological dose underestimation could be associated with the relative decreased dose rate met in modulated techniques compared to the conventional 3D-CRT irradiations.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Nikolakopoulou, Angeliki
- Νικολακοπούλου, Αγγελική
Subjects
dc:subject × 16- Ακτινοθεραπεία
- Κυτταρογενετικές μεθοδολογίες
- Νικολακοπούλου Αγγελική
- Τοξοειδής ακτινοθεραπεία διαμορφωμένης έντασης
- Βιοδοσιμετρία
- Cytogenetics
- Radiotherapy
- VMAT
- Nikolakopoulou Aggeliki
- Biodosimetry
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες υγείας, γενικά
- Health Sciences
- Medical and Health Sciences
- Health sciences, general
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/50052